Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Observational 2

Sponsor

Conditions

Multiple Myeloma 5Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 3Melanoma 3Leukemia, Myeloid, Acute 3Leukemia 3Carcinoma, Non-Small-Cell Lung 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematologic Neoplasms 2Craniopharyngioma 2COVID-19 2Burkitt Lymphoma 2Arthritis, Rheumatoid 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Unresectable Pancreatic Carcinoma 1Triple Negative Breast Neoplasms 1Stroke 1Sarcoma 1Respiratory Tract Infections 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Etanercept 12Adalimumab 12Infliximab 7golimumab 4Tumor Necrosis Factor Inhibitors 4Certolizumab Pegol 4Abatacept 4tofacitinib 2tocilizumab 2Rituximab 2Antirheumatic Agents 2Vitamin D 1Vaccines 1Syringes 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Saline Solution 1Radioimmunodetection 1Prednisone 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Nivolumab 1Methotrexate 1Methods 1Lysine Acetyltransferase 5 1Licensure 1Leflunomide 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Arthritis, Rheumatoid × tocilizumab × Clear all
NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02778789 2019-09-26

Re-Bone

University of Erlangen-Nürnberg Medical School

Completed
66 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡